Modanlou Kian A, Muthyala Umadevi, Xiao Huiling, Schnitzler Mark A, Salvalaggio Paolo R, Brennan Daniel C, Abbott Kevin C, Graff Ralph J, Lentine Krista L
Division of Abdominal Organ Transplantation, Department of Surgery, Saint Louis University Medical Center, St. Louis, MO 63130, USA.
Transplantation. 2009 Apr 27;87(8):1167-73. doi: 10.1097/TP.0b013e31819e3f14.
Limited data exist on the safety and efficacy of bariatric surgery (BS) in patients with kidney failure.
We examined Medicare billing claims within USRDS registry data (1991-2004) to identify BS cases among renal allograft candidates and recipients.
Of 188 BS cases, 72 were performed pre-listing, 29 on the waitlist, and 87 post-transplant. Roux-en-Y gastric bypass was the most common procedure. Thirty-day mortality after BS performed on the waitlist and post-transplant was 3.5%, and one transplant recipient lost their graft within 30 days after BS. BMI data were available for a subset and suggested median excess body weight loss of 31%-61%. Comparison to published clinical trials of BS in populations without kidney disease indicates comparable weight loss but higher post-BS mortality in the USRDS sample.
Given the substantial contributions of obesity to excess morbidity and mortality, BS warrants prospective study as a strategy for improving outcomes before and after kidney transplantation.
关于减肥手术(BS)在肾衰竭患者中的安全性和有效性的数据有限。
我们在美国肾脏数据系统(USRDS)登记数据(1991 - 2004年)中检查了医疗保险计费索赔,以识别肾移植候选者和接受者中的减肥手术病例。
在188例减肥手术病例中,72例在列入名单前进行,29例在等待名单上进行,87例在移植后进行。Roux - en - Y胃旁路术是最常见的手术方式。在等待名单上和移植后进行减肥手术后30天死亡率为3.5%,一名移植受者在减肥手术后30天内失去了移植肾。部分患者有体重指数(BMI)数据,提示多余体重减轻中位数为31% - 61%。与已发表的无肾脏疾病人群减肥手术临床试验相比,USRDS样本中的体重减轻情况相当,但减肥手术后死亡率更高。
鉴于肥胖对额外发病率和死亡率有重大影响,减肥手术作为一种改善肾移植前后结局的策略值得进行前瞻性研究。